Growth Metrics

Quest Diagnostics (DGX) Consolidated Net Income (2017 - 2026)

Quest Diagnostics' Consolidated Net Income history spans 14 years, with the latest figure at $260.0 million for Q1 2026.

  • On a quarterly basis, Consolidated Net Income rose 19.82% to $260.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.0 billion, a 13.93% increase, with the full-year FY2025 number at $1.0 billion, up 11.31% from a year prior.
  • Consolidated Net Income hit $260.0 million in Q1 2026 for Quest Diagnostics, up from $249.0 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for DGX hit a ceiling of $342.0 million in Q1 2022 and a floor of $113.0 million in Q4 2022.
  • Historically, Consolidated Net Income has averaged $236.4 million across 5 years, with a median of $240.0 million in 2024.
  • Biggest five-year swings in Consolidated Net Income: plummeted 70.88% in 2022 and later surged 74.34% in 2023.
  • Tracing DGX's Consolidated Net Income over 5 years: stood at $113.0 million in 2022, then surged by 74.34% to $197.0 million in 2023, then increased by 17.26% to $231.0 million in 2024, then grew by 7.79% to $249.0 million in 2025, then increased by 4.42% to $260.0 million in 2026.
  • Business Quant data shows Consolidated Net Income for DGX at $260.0 million in Q1 2026, $249.0 million in Q4 2025, and $251.0 million in Q3 2025.